Correlation Between Vanda Pharmaceuticals and China Pharma

Can any of the company-specific risk be diversified away by investing in both Vanda Pharmaceuticals and China Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vanda Pharmaceuticals and China Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Vanda Pharmaceuticals and China Pharma Holdings, you can compare the effects of market volatilities on Vanda Pharmaceuticals and China Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vanda Pharmaceuticals with a short position of China Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vanda Pharmaceuticals and China Pharma.

Diversification Opportunities for Vanda Pharmaceuticals and China Pharma

-0.37

Correlation Coefficient

Vanda Pharmaceuticals  China Pharma

Very good diversification

The 3 months correlation between Vanda and China is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Vanda Pharmaceuticals and China Pharma Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on China Pharma Holdings and Vanda Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vanda Pharmaceuticals are associated (or correlated) with China Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of China Pharma Holdings has no effect on the direction of Vanda Pharmaceuticals i.e., Vanda Pharmaceuticals and China Pharma go up and down completely randomly.

Pair Corralation between Vanda Pharmaceuticals and China Pharma

Given the investment horizon of 90 days Vanda Pharmaceuticals is expected to generate 0.65 times more return on investment than China Pharma. However, Vanda Pharmaceuticals is 1.54 times less risky than China Pharma. It trades about 0.0 of its potential returns per unit of risk. China Pharma Holdings is currently generating about -0.05 per unit of risk. If you would invest  654.00  in Vanda Pharmaceuticals on October 3, 2024 and sell it today you would lose (175.00) from holding Vanda Pharmaceuticals or give up 26.76% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Vanda Pharmaceuticals  vs.  China Pharma Holdings

Vanda Pharmaceuticals

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Vanda Pharmaceuticals are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unfluctuating fundamental indicators, Vanda Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in February 2025.

China Pharma Holdings

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days China Pharma Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong technical indicators, China Pharma is not utilizing all of its potentials. The latest stock price confusion, may contribute to short-horizon losses for the traders.

Pair Trading with Vanda Pharmaceuticals and China Pharma

The main advantage of trading using opposite Vanda Pharmaceuticals and China Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vanda Pharmaceuticals position performs unexpectedly, China Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in China Pharma will offset losses from the drop in China Pharma's long position.

The idea behind Vanda Pharmaceuticals and China Pharma Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.